Russell Z. Szmulewitz to Cyclin-Dependent Kinase 4
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Cyclin-Dependent Kinase 4.
Connection Strength
0.051
-
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1531-1539.
Score: 0.051